Ira A. Rosenberg is a Member of Sills Cummis & Gross and Co-Chair of
the Corporate Practice Group and Chair of the Life Sciences Practice Group. Mr.
Rosenberg has more than 30 years’ experience representing life science and
health care technology companies, ranging in size from start-ups to public
companies, in corporate and intellectual property transactions and general
corporate matters. This work has included numerous product and technology
acquisition, development, licensing, supply and distribution transactions,
venture capital financings, mergers and acquisitions, strategic alliances and
joint ventures. He has structured and negotiated corporate partnering
transactions with numerous global and other large pharmaceutical companies. He
has been recognized by being named by Chambers USA 2008-2020 for New Jersey
Corporate/M&A, The Best Lawyers in America 1995-2021 for Corporate Law;
Mergers and Acquisitions Law, IFLR1000 United States: Guide to USA’s Leading
Financial and Corporate Law Firms 2018-2019 for “Highly Regarded” New Jersey
M&A and New Jersey Super Lawyers 2005-2020 for Mergers & Acquisitions;
Securities & Corporate Finance.